Clinical Trial Update: RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating RK-4 Intracalvariosseous Injection for acute large hemispheric infarction (ischemic stroke), currently not yet recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• RK-4 Intracalvariosseous Injection

Snippet

Sponsor: Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd | Conditions: Acute Large Hemispheric Infarction Stroke, Transcranial Bone Marrow Injection | Phase 2 | Status: NOT_YET_RECRUITING